The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition.
Zhao L, Huang L, Zhang J, Fan J, He F, Zhao X, Wang H, Liu Q, Shi D, Ni N, Wagstaff W, Pakvasa M, Fu K, Tucker AB, Chen C, Reid RR, Haydon RC, Luu HH, Shen L, Qi H, He TC.
Zhao L, et al. Among authors: zhao x.
Am J Transl Res. 2020 Dec 15;12(12):8084-8098. eCollection 2020.
Am J Transl Res. 2020.
PMID: 33437383
Free PMC article.